Vertical Farming Controlled Environment Indoor AgGold report
Published May 2026Insight Research27 min read2027 Edition20 sources, 20 primary-gradeVery high source depth

Thailand Vertical Farming & Indoor Ag 2027 Market Intelligence

Thai controlled-environment agriculture and indoor vertical-farm footprint stepped from ~5-8 sites in 2020 to ~25-40 in 2024; 2027 thesis lifts the market from THB 0.8-1.4B to THB 4-7B as BOI Section 8, FDA cannabis medical-grow, and PTT, B.Grimm captive bays compound.

Key takeaways

  1. 1

    Thai controlled-environment agriculture (CEA) and indoor vertical-farm footprint stepped from an estimated 5-8 commercial sites in 2020 to 25-40 in 2024. Insight base case carries the market from an estimated 2024 toward by 2027 on the BCG bio-circular-green policy stack, BOI Section 8 incentives, FDA medical-cannabis licensing, and direct-to-consumer brand build.

  2. 2

    Policy stack: BOI Section 8 promoted activities offer up to five years of corporate tax holiday plus import-duty exemption on hydroponic and LED equipment; the BCG bio-circular-green economy model (NXPO 2021-2027 strategy) anchors CEA as a priority cluster.

  3. 3

    Anchor operators: Wongnok Farm Tech, Thai Farming Tech, NongPlus AgriTech (PTT NRPT partner), PTT NRPT industrial-estate captive bays, B.Grimm AgriTech Amata pilot, UrbanBuoy and Tama Farm Bangkok direct-to-consumer, Habiterre Chiang Mai, Royal Project Foundation highland research plots.

  4. 4

    Cannabis medical-grow recriminalisation in 2025 redirects indoor-grow capex into FDA GAP and GMP licensed facilities. Insight estimates 80-120 active operations in 2024, projecting 250-350 by 2027; the segment captures roughly of 2027 CEA revenue.

  5. 5

    Our 2027 read: CEA scales as a credentialed premium-produce and medical-grow play, gated by Ft electricity tariff trajectory, FDA licence cadence, and the imported LED, nutrient-automation cost-down curve from Heliospectra, Signify and Priva.

Executive summary

Thailand's controlled-environment agriculture and indoor vertical-farming layer is one of the country's more credentialed but still under-measured agtech segments. Insight estimates roughly 25-40 commercial sites operating in 2024, up from an estimated 5-8 in 2020. Headline revenue sits at an estimated in 2024, derived from BOI Section 8 promoted-investment disclosures, operator press, the NSTDA BIOTEC Pathum Thani pilot scale, and a Thai-share take on the Grand View Research global vertical-farming benchmark ( in 2024 to by 2030 at ~ CAGR).[, , , ]

The 2027 catalyst stack is unusually dense. BOI Section 8 promoted activities under the BCG bio-circular-green economy model carry up to a five-year corporate income tax holiday and import-duty exemption on hydroponic equipment, LED horticulture lighting and nutrient-dosing automation. NSTDA BIOTEC operates a plant-factory pilot at Thailand Science Park in Pathum Thani that hands functional-food, medicinal-plant and high-value-vegetable bays to commercial partners. PTT Group's NRPT (Nature Reserve Plant Technology) joint venture with NongPlus AgriTech, and B.Grimm Power's AgriTech captive pilot at Amata Industrial Estate, signal that listed Thai energy and industrial groups treat CEA as both a downstream offtake play and a green-credential capex line.[, , , ]

The thesis: by 2027 the headline Thai CEA and indoor vertical-farm market reaches , an Insight base case roughly 3.5x the 2024 anchor. The mix is bifurcated. FDA cannabis medical-grow specialists, recapitalised after the 2025 recriminalisation of recreational use, capture an estimated of revenue on a base case of roughly 250-350 GAP and GMP licensed operations (versus 80-120 in 2024). Commercial leafy-green, herb, microgreen, strawberry-tunnel and direct-to-consumer subscription operators capture the remainder. The binding 2027 variables are electricity tariff trajectory (the Ft formula), FDA licence cadence, and the cost-down curve on imported Heliospectra, Signify Philips and Priva equipment, which penetrate roughly of new commercial builds.[, , , , ]

BOI, NSTDA, FDA, NXPO, SCB EIC, operator disclosures, Grand View global benchmark
Data as of: 2024-2026

Thai CEA and indoor vertical-farm market size (THB billion, 2020-2027F)

2020

Revenue (THB B)

~0.4

Facilities

~5-8

Context

Pre-policy: pilot pods, Royal Project highland tunnels, early hydroponic

2021

Revenue (THB B)

~0.6

Facilities

~8-12

Context

BCG model announced; early BOI Section 8 promoted projects

2022

Revenue (THB B)

~0.9

Facilities

~12-18

Context

Cannabis decriminalisation drives indoor-grow capex

2023

Revenue (THB B)

~1.1

Facilities

~18-25

Context

Wongnok, Thai Farming Tech, UrbanBuoy commercial scale

2024

Revenue (THB B)

~1.3

Facilities

~25-40

Context

PTT NRPT, B.Grimm AgriTech captive pilots launch

2025E

Revenue (THB B)

~2.1

Facilities

~45-65

Context

Cannabis recriminalisation redirects capex to FDA medical-only

2026E

Revenue (THB B)

~3.4

Facilities

~80-110

Context

BIOTEC pilot hand-off; medical-grow licensees compound

2027F

Revenue (THB B)

~5.2

Facilities

~140-190

Context

Base case: $0.116-7B; medical-grow ~40-50% share

Insight derivation from BOI Section 8, NSTDA BIOTEC, FDA narcotics registry, SCB EIC outlook, Grand View global benchmark
Data as of: 2024-2026

End-use revenue mix (% of 2026E CEA market)

Cannabis medical-grow GAP, GMP licensed

Share %

45%

Notes

Pharmaceutical-input pricing absorbs high kWh per kg; FDA-gated

Leafy greens (lettuce, kale, mizuna)

Share %

22%

Notes

Modern-trade premium retail, HORECA, hotel cafeterias

Culinary herbs (basil, mint, coriander)

Share %

12%

Notes

HORECA, premium retail; smaller volume, higher gross margin

Microgreens

Share %

7%

Notes

Bangkok restaurants, hotel breakfast buffets, D2C subscription brands

Strawberry tunnels and high-value produce

Share %

9%

Notes

Royal Project highland tunnels, polytunnel CEA hybrid, premium hampers

Other (functional herbs, edible flowers, seedlings)

Share %

5%

Notes

BIOTEC research bays, specialty wellness, seedling propagation

Insight derivation from FDA registry, BOI Section 8, operator press, BIOTEC pilot
Data as of: 2026E

Analyst framing

Why this report

Thai CEA and indoor vertical farming is a credentialed premium-produce and medical-grow play built on the BCG policy stack, BOI Section 8 incentives, FDA cannabis medical-grow licensing, and listed-corporate captive pilots from PTT and B.Grimm. This report maps facility count, end-use mix, operator concentration, unit economics, the policy framework and scenarios to 2031.

Unlock the full report

Operator playbooks, unit economics (kWh per kg, CapEx per sqm, harvest cycles), concentration table, regulation framework, scenarios to 2031, recommended actions and full company list.
Unlock full reportΒ·$299-$349

Need more than the web report? Ask for a scoped export or source appendix.

Every report keeps visible citations and source metadata. Terms.

Key figures

Selected anchors from the report evidence pack.

Related reports

Thailand Agritourism, Farm-Stay and Rural Wellness 2027 Market Intelligence

Thailand's agritourism, farm-stay and rural-wellness layer generates an estimated THB 6-9B in 2026, anchored by the GSTC-recognised CBT Thailand standard, DASTA's nine SOUL OF THAILAND routes, royal-project estates (Doi Tung, Doi Chaang), Chanthaburi-Rayong durian orchards, Mae Kampong forest-village and Sangkhlaburi Mon-Karen agroforestry. The 2027 thesis: rural revival reframed as soft-power and climate-adaptation, with Indian and ASEAN inbound packages turning village hospitality from charity case into margin segment.

Open report β†’

Thailand AI Enterprise Adoption 2027 Market Intelligence

Thai enterprise AI adoption sits at roughly 25-35% of SET-100 large corporates in 2026, still nascent compared with Singapore and Korea but accelerating. Three structural tailwinds carry the sector to 2027: hyperscaler GPU-cluster maturation (AWS Bangkok USD 5B+, Google Cloud USD 1B+ Chonburi, Microsoft's March 2026 GPU commitment), Thai-language vertical AI on Typhoon (SCB 10X open-weight) and NSTDA ThaiLLM, and the BOI Category 1.6, 1.7 incentive plus the AI Engineer Visa pipeline. Domestic studios (PandaAI, Botnoi, Sertis, AI Engineer Studio, BeyondX, Pyth) anchor document automation, customer service, fraud detection, and vertical knowledge retrieval. Report maps adoption tiers, compute layer mix, operator concentration, and 2027 scenarios.

Open report β†’

Thailand Cold-Pressed Juice & Functional Beverage 2027 Market Intelligence

Thailand's health and wellness beverage category generated an estimated THB 95-105B in 2026, anchored by Osotspa's 37 percent functional and 54.8 percent energy share, Carabao Group's carbonated vitamin line (up 26 percent YoY in 2024), TC Pharmaceutical's Sponsor (73.5 percent sports-drink share) and Yanhee's 32 percent vitamin-water lead, with an emerging premium tier of cold-pressed HPP juice (Fresher Kitchen Beep, License To Blend, MyJuiceBkk), kombucha (Fermenthe), and fortified plant-milk (Lactasoy, Dutch Mill). The 2027 thesis: sugar tax phase four (2025), the national 90 percent low-sugar consumer target by 2027, and the June 2025 cannabis recontrol together force the category from energy-drink mass into clean-label premium where HPP juice, probiotic and adaptogen formats earn structurally higher margins.

Open report β†’

Thailand Vertical Farming & Indoor Ag 2027 Market Intelligence Β· Insight